Discontinued — last reported Q3 '20

Financing

Repayments of lines of credit

Labcorp Holdings Repayments of lines of credit decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $64.80M to $0.00.

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ2 2019
Last reportedQ3 2020
Metric ID: tmusz_repayments_of_lines_of_credit

Historical Data

14 periods
 Q2 '21Q3 '21Q4 '21Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$0.00$0.00$0.00$787.40M$827.90M$593.00M$458.00M$609.30M$210.80M$721.30M$1.53B$0.00$64.80M$0.00
QoQ Change+5.1%-28.4%-22.8%+33.0%-65.4%+242.2%+112.3%-100.0%-100.0%
YoY Change-22.6%-74.5%+21.6%+234.4%-100.0%-69.3%-100.0%
Range$0.00$1.53B
Avg YoY Growth-15.8%
Median YoY Growth-69.3%
Current Streak3 quarters decline

Frequently Asked Questions

What is Labcorp Holdings's repayments of lines of credit?
Labcorp Holdings (LH) reported repayments of lines of credit of $0.00 in Q1 2026.
How has Labcorp Holdings's repayments of lines of credit changed year-over-year?
Labcorp Holdings's repayments of lines of credit decreased by 100.0% year-over-year, from $64.80M to $0.00.